Table 1.
Association of CXCR2 expression with patient characteristics
| CXCR2 low | CXCR2 high | Total | P | |
|---|---|---|---|---|
| Score stage | ||||
| Late | 136 | 89 | 225 | |
| Early | 14 | 1 | 15 | |
| Total | 150 | 90 | 240 | 0.005 |
| Family history | ||||
| Yes | 78 | 36 | 114 | |
| No | 65 | 53 | 118 | |
| Unknown | 7 | 1 | 8 | |
| Total | 150 | 90 | 240 | 0.031 |
| Age at diagnosis (y) | ||||
| ≥60 | 78 | 53 | 131 | |
| <60 | 72 | 37 | 109 | |
| Total | 150 | 90 | 240 | 0.286 |
| Relapse | ||||
| Yes | 69 | 37 | 106 | 0.045* |
| Progressive disease | 50 | 46 | 96 | 0.004† |
| No | 16 | 3 | 19 | 0.059‡ |
| Unknown | 15 | 4 | 19 | |
| Total | 150 | 90 | 240 | |
| Level of debulking surgery | ||||
| Optimal | 81 | 41 | 122 | |
| Suboptimal | 59 | 47 | 106 | |
| Unknown | 9 | 2 | 11 | |
| No surgery | 1 | 0 | 1 | |
| Total | 150 | 90 | 240 | 0.124 |
| Clinical response | ||||
| Complete | 80 | 40 | 120 | 0.171§ |
| Partial | 30 | 23 | 53 | 0.473‖ |
| None | 13 | 13 | 26 | 0.070¶ |
| Unknown | 27 | 14 | 41 | |
| Total | 150 | 90 | 240 | |
| Ascites | ||||
| No | 8 | 6 | 14 | 0.779** |
| Yes | 91 | 69 | 160 | 0.241†† |
| Unknown | 46 | 14 | 60 | 0.122‡‡ |
| Minimal | 5 | 1 | 6 | |
| Total | 150 | 90 | 240 | |
| Chemoresponse | ||||
| Chemoresistant | 42 | 46 | 88 | |
| Chemosensitive | 76 | 37 | 113 | |
| Total | 118 | 83 | 201 | 0.004 |
Yes versus progressive disease.
Progressive disease versus no.
Yes versus no.
Complete versus partial.
Partial versus none.
Complete versus none.
No versus yes.
Yes versus minimal.
No versus minimal.